ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Esperion Therapeutics Inc

Esperion Therapeutics Inc (ESPR)

2.68
0.06
(2.29%)
At close: March 28 04:00PM
2.68
0.06
( 2.29% )
After Hours: 04:23PM

Esperion Therapeutics Inc Financial Summary

The current ESPR market cap is 495.94M. The company's latest EPS is USD -1.1307 and P/E is -2.37.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 18.98M18.82M24.33M25.79M33.97M
Operating Income -41.62M-42.51M-48.61M-37.06M-27.53M
Net Income -55.12M-55.49M-61.72M-49.94M-41.25M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 148.36M227.55M78.45M75.48M116.33M
Operating Income -93.1M-121.4M-226.73M-179.5M-155.56M
Net Income -97.17M-143.55M-269.11M-233.66M-209.25M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 312.83M247.94M251.82M234.63M221.31M
Total Liabilities 606.93M571.72M581.48M606.6M631.31M
Total Equity -294.1M-323.78M-329.66M-371.98M-410M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 214.45M353.26M381.59M247.94M205.8M
Total Liabilities 194.5M449.39M578.53M571.72M660.79M
Total Equity 19.95M-96.13M-196.94M-323.78M-454.99M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -132.36M-174.83M-54.36M-79.11M-98.43M
Investing 19.9M8.1M25M42.5M42.5M
Financing 62.96M32.61M49.49M50.3M45.99M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -70.34M-85.18M-263.81M-174.83M-135.49M
Investing 64.23M21.36M-50.48M8.1M42.5M
Financing 136.2M201.73M268.22M32.61M50.46M
Market Cap 495.94M
Price to Earnings Ratio -2.37
Price to Sales Ratio 4.26
Price to Cash Ratio 6.03
Price to Book Ratio -1.09
Dividend Yield -

Share Statistics

Shares Outstanding 185.05M
Average Volume (1 week) 14.57M
Average Volume (1 Month) 6.47M
52 Week Change 53.14%
52 Week High 3.335
52 Week Low 0.70
Spread (Intraday) 0.02 (0.75%)

Company Info

Company Name Esperion Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.esperion.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock